rx 821002 has been researched along with nandrolone in 1 studies
| Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (nandrolone) | Trials (nandrolone) | Recent Studies (post-2010) (nandrolone) |
|---|---|---|---|---|---|
| 317 | 0 | 45 | 2,995 | 314 | 531 |
| Protein | Taxonomy | rx 821002 (IC50) | nandrolone (IC50) |
|---|---|---|---|
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.0031 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kindlundh, A; Lindblom, J; Mugisha, P; Nyberg, F; Uhlén, S | 1 |
1 other study(ies) available for rx 821002 and nandrolone
| Article | Year |
|---|---|
Nandrolone treatment decreases the level of rat kidney alpha(1B)-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Anabolic Agents; Animals; Idazoxan; Injections, Intramuscular; Kidney; Ligands; Male; Nandrolone; Prazosin; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Spleen | 2003 |